Home › Research › Risk genes beyond APOE
About genotype and allele distributions of APP promoter single-nucleotide polymorphisms
A. Chikhradze, M. Kacharava, A. Surmanidze, Shorena Vashadze. INTERNATIONAL NEUROLOGICAL JOURNAL, 2025-05-20
Topic: Brain proteins, microglia and lab models
Plain-language summary
Background. Alzheimer’s disease is caused by progressive degeneration of the central nervous system and is the most prevalent form of dementia in the elderly. The -amyloid precursor protein (-APP or APP), which generates the neurotoxic amyloid beta, appears to play an important role in the pathogenesis of Alzheimer’s disease. The purpose of the study is to determine the APP gene polymorphism in individuals with Alzheimer’s disease and a control group. Materials and methods. The study is approved by the Ethics Committee of Medcenter Clinic (Batumi, Georgia) and was conducted there. It had a case-control design. Sixty-seven Alzheimer patients were recruited. The control group (n = 50) consisted of healthy, age-matched individuals. Both parties were asked to sign an informed consent form, and their clinical information was obtained from medical charts. The mean age for cases were 68.00 ± 9.43 years, whereas control subjects had a mean age of 65.0 ± 10.2 years. Results. In this study, the rs463946 polymorphism in the APP gene was analyzed. Demographic characteristics of cases and controls were investigated. The average age of cases (68 years) was slightly higher than that of controls (65 years), although this difference does not reach statistical significance (p = 0.11). Under the codominant model, the odds ratio (OR) of 0.45 (CC vs. GC) suggest that individuals with the CC genotype have lower odds of being a case compared to those having the heterozygote (GC), but this difference is not statistically significant (p = 0.27). The OR of 2.49 (GG vs. GC) indicates that individuals with the GG genotype have significantly higher odds of being a case compared to those with the heterozygote (GC) (p = 0.04). In addition, the OR (C vs. G) indicates that the C allele is less frequent in cases (p = 0.043). These results support the hypothesis that the C allele (when present in one copy) has a protective effect. Conclusions. The obtained data is noteworthy. Genetic research into dementia continues to help many people around the world. These data require further research using larger population samples of different age categories.
What this study adds
Evidence grade: Moderate
This is a case-control study of 50 participants. This case-control study examined an APP gene polymorphism and found that the GG genotype was associated with significantly higher odds of being an Alzheimer's case, while the C allele was less frequent in cases. It is a genetic association study and does not test or demonstrate any treatment, cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Chikhradze, A., Kacharava, M., Surmanidze, A., & Vashadze, S. (2025). About genotype and allele distributions of APP promoter single-nucleotide polymorphisms. INTERNATIONAL NEUROLOGICAL JOURNAL. https://doi.org/10.22141/2224-0713.21.3.2025.1172
Vancouver
Chikhradze A, Kacharava M, Surmanidze A, Vashadze S. About genotype and allele distributions of APP promoter single-nucleotide polymorphisms. INTERNATIONAL NEUROLOGICAL JOURNAL. 2025. doi:10.22141/2224-0713.21.3.2025.1172.
BibTeX
@article{chikhradze2025-00095b0c,
author = {Chikhradze, A. and Kacharava, M. and Surmanidze, A. and Vashadze, Shorena},
title = {{About genotype and allele distributions of APP promoter single-nucleotide polymorphisms}},
journal = {INTERNATIONAL NEUROLOGICAL JOURNAL},
year = {2025},
doi = {10.22141/2224-0713.21.3.2025.1172},
url = {https://doi.org/10.22141/2224-0713.21.3.2025.1172}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- GC) suggest that individuals with the CC genotype have lower odds of being a case compared to those having the heterozygote (GC), but this difference is not statistically significant (p = 0.27).
- GC) indicates that individuals with the GG genotype have significantly higher odds of being a case compared to those with the heterozygote (GC) (p = 0.04).
- G) indicates that the C allele is less frequent in cases (p = 0.043).
- These results support the hypothesis that the C allele (when present in one copy) has a protective effect.
Why it matters
This case-control study examined an APP gene polymorphism and found that the GG genotype was associated with significantly higher odds of being an Alzheimer's case, while the C allele was less frequent in cases. It is a genetic association study and does not test or demonstrate any treatment, cure or prevention.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designcase-control study
- Participants50
- Evidence strengthModerate
How this study scored 37/100
Published in a peer-reviewed journal, and it is a case-control study. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (INTERNATIONAL NEUROLOGICAL JOURNAL) |
| Journal's citation record | 0 / 4 | INTERNATIONAL NEUROLOGICAL JOURNAL: journal h-index 8 (OpenAlex, 2026-10-29) |
| Study design | 6 / 12 | A case-control study |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 1 / 4 | 50 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 0 / 4 | Last-listed author Shorena Vashadze: h-index 3 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Batumi Shota Rustaveli State University: institution h-index 31 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 37 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.22141/2224-0713.21.3.2025.1172
- Original source →
- Free full text: INTERNATIONAL NEUROLOGICAL JOURNAL →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Risk genes beyond APOE from nearby years
Also in Risk genes beyond APOE
103 studies in the library are filed under Risk genes beyond APOE with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk genes beyond APOE hub.